2,000
Participants
Start Date
February 27, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
Colchicine 0.5 mg
The intervention group will receive 0.5mg of oral colchicine daily as soon as possible after randomization, to continue for 30 days.
Deferoxamine Mesylate
The intervention group will receive deferoxamine mesylate at a dose of 32mg/kg/day via intravenous infusion immediately (within 1 hour) and continued for 2 consecutive days
Control (Standard treatment)
The group will not receive deferoxamine mesylate or colchicine
NOT_YET_RECRUITING
Royal Prince Alfred Hospital, Sydney
RECRUITING
West China Hospital of Sichuan University, Chengdu
University of Calgary
OTHER
The George Institute
OTHER